Home/Filings/4/0001179110-11-001454
4//SEC Filing

EYLENBOSCH HILDE 4

Accession 0001179110-11-001454

CIK 0001145460other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 3:55 PM ET

Size

8.4 KB

Accession

0001179110-11-001454

Insider Transaction Report

Form 4
Period: 2011-01-26
EYLENBOSCH HILDE
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2011-01-26$14.92/sh+4,000$59,68033,303 total(indirect: By Spouse)
  • Exercise/Conversion

    Common Stock

    2011-01-264,0000 total(indirect: By Spouse)
    Exercise: $14.92From: 2001-11-21Exp: 2011-02-12Common Stock (4,000 underlying)
Holdings
  • Common Stock

    4,448
Footnotes (3)
  • [F1]This option was acquired through a restructuring transaction undertaken by the Issuer's former parent, Inverness Medical Technology, Inc. in connection with the consummation of the transactions contemplated by the agreement and plan of split-off merger dated as of May 23, 2001 among Johnson & Johnson, Sunrise Acquisition Corp. and Inverness Medical Technology, Inc.
  • [F2]This derivative security does not have a price.
  • [F3]The reporting person disclaims beneficial ownership of the reported securities.

Issuer

ALERE INC.

CIK 0001145460

Entity typeother

Related Parties

1
  • filerCIK 0001272540

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 3:55 PM ET
Size
8.4 KB